|
, . , . , . , .
|
|
|
(RBC) |
, . (), (). ( ), .
|
4.3 - 6.2 10 12 /
3.8-5.5 10 12 / |
(HGB, Hb) |
– , . () . , , , .
|
120 - 140 / |
(HCT) |
- , , . : , () 39% , 39% . ( ), . ( ), .
|
39 – 49%
35 – 45%
|
(RDWc) |
- , , . , , . - .
|
11,5 - 14,5% |
(MCV) |
. (), (3). . , 12, .
|
80 - 100 |
(MCH) |
, . (). , , 12, .
|
26 - 34 (pg) |
() |
, . , ( ). .
|
30 - 370 / (g/l) |
(PLT) |
– , . , , . , .
|
180 – 320 × 10 9 / |
(WBC) |
. , , , , .
|
4,0 – 9,0 × 10 9 / |
(LYM) |
– , . ( ), ( ). , , LYM# LYM. LYM% LY%. () . () , , .
|
LY% 25-40%
LYM# 1,2 - 3,010 9 / ( 1,2-63,0 103/) |
, , (MID, MXD) |
, , , , MID MXD. (MXD%), (MXD#, MID#). ( , , .)
|
MID# (MID, MXD#) 0,2-0,8 x 10 9 /
MID% (MXD%) 5 – 10%
|
(GRA, GRAN) |
– , ( ). 3 : , . , . (GRA#) (GRA%). . , , . |
GRA# 1,2-6,8 10 9 / ( 1,2-6,8 10 3 /) GRA% 47 - 72% |
(MON) |
– , , , , (, ). (MON#) (MON%). , , . , , . |
MON% 4 – 10% MON# 0.1-0.7 10 9 / ( 0,1-0,7 10 3 /)
|
(, ESR) |
– , . - . , , . (), . |
10 / 15 / |
|
, |
|
: | [1] |